Related Experiment Video
Updated: Sep 18, 2025
05:59
Author Spotlight: Overcoming Challenges in Drosophila Sleep Measurement Using DAM System
Published on: October 20, 2023
2.6K
[Trazodone in psychogeriatric care].
Maximilian Gahr1, Berthold Merz1
1Krankenhaus für Psychiatrie, Psychotherapie und Psychosomatische Medizin Schloß Werneck, Werneck, Germany.
Fortschritte Der Neurologie-Psychiatrie
|June 23, 2025
Summary
Trazodone, an antidepressant, shows efficacy in treating depression and sleep disturbances in elderly patients, including those with dementia. Research suggests potential neuroprotective effects and delayed cognitive decline in Alzheimer's patients.
Area of Science:
- Pharmacology
- Geriatric Psychiatry
- Neuroscience
Context:
- Trazodone is a dual serotonergic antidepressant with sedative and hypnotic properties.
- It is used for depression, particularly in elderly patients, and has shown benefits in those with cognitive dysfunction.
- Adverse effects include orthostatic hypotension, sedation, QTc prolongation, and priapism.
Purpose:
- To review the efficacy and safety of trazodone in elderly patients with depression and cognitive impairment.
- To explore trazodone's potential neuroprotective effects and impact on cognitive decline.
- To assess its role in managing behavioral and psychological symptoms of dementia.
Summary:
- Trazodone demonstrates efficacy in treating depression and sleep disturbances in elderly individuals, including those with dementia.
- Evidence supports its use for agitation and motor unrest in frontotemporal dementia, though data is limited.
- Animal studies suggest neuroprotection via inhibition of the unfolded protein response (UPR), and human studies link trazodone use to delayed cognitive decline in Alzheimer's disease.
Impact:
- Trazodone offers a therapeutic option for depression and sleep issues in the elderly, even with cognitive impairment.
- Potential neuroprotective properties warrant further investigation for managing neurodegenerative diseases.
- Understanding trazodone's multifaceted effects can optimize its clinical application in geriatric populations.
Related Concept Videos
01:23Antidepressant Drugs: MAOIs and Other Agents
378
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
378
01:24Parkinson's Disease: Treatment
391
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
391
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
248
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
248
01:26Psychosis: Goals of Pharmacotherapy
214
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
214
01:28Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
625
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
625
01:28Drug Therapy
107
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
107